C
C. Gillham
Researcher at Mount Sinai St. Luke's and Mount Sinai Roosevelt
Publications - 33
Citations - 1134
C. Gillham is an academic researcher from Mount Sinai St. Luke's and Mount Sinai Roosevelt. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 9, co-authored 24 publications receiving 759 citations.
Papers
More filters
Journal ArticleDOI
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
Alina Sturdza,Richard Pötter,Lars Fokdal,Christine Haie-Meder,Li Tee Tan,Renaud Mazeron,Primoz Petric,Barbara Segedin,Ina M. Jürgenliemk-Schulz,C. Nomden,C. Gillham,Orla McArdle,Erik Van Limbergen,Hilde Janssen,Peter Hoskin,Gerry Lowe,Ekkasit Tharavichitkul,E. Villafranca,Umesh Mahantshetty,Petra Georg,Kathrin Kirchheiner,Christian Kirisits,Kari Tanderup,Jacob Christian Lindegaard +23 more
TL;DR: IGBT combined with radio-chemotherapy leads to excellent LC (91%), PC (87%), OS (74%), CSS (79%) with limited severe morbidity.
Journal ArticleDOI
Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study.
Lars Fokdal,Alina Sturdza,Renaud Mazeron,Christine Haie-Meder,Li Tee Tan,C. Gillham,Barbara Segedin,Ina Jürgenliemk-Schultz,Christian Kirisits,Peter Hoskin,Richard Pötter,Jacob Christian Lindegaard,Kari Tanderup +12 more
TL;DR: Combined IC/IS brachytherapy improves the therapeutic ratio in LACC by enabling a tumour specific dose escalation resulting in significantly higher local control in large tumours without adding treatment related late morbidity.
Journal ArticleDOI
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
Anne Sophie V M van den Heerik,Nanda Horeweg,Remi A. Nout,Ludy C.H.W. Lutgens,Elzbieta van der Steen-Banasik,G Henrieke Westerveld,Hetty A. van den Berg,Annerie Slot,F. Koppe,Stefan Kommoss,Jan Willem M. Mens,Marlies E. Nowee,Stefan Bijmolt,David Cibula,Tanja C. Stam,Ina M. Jürgenliemk-Schulz,An Snyers,Moritz Hamann,Aleida G Zwanenburg,Veronique L M A Coen,Katrien Vandecasteele,C. Gillham,Cyrus Chargari,Karen W Verhoeven-Adema,Hein Putter,Wilbert B. van den Hout,Bastiaan G Wortman,Hans W. Nijman,Tjalling Bosse,Carien L. Creutzberg +29 more
TL;DR: A multicenter, international phase III randomized trial to compare the rates of vaginal recurrence in women with high-intermediate risk endometrial cancer, treated after surgery with molecular-integrated risk profile-based recommendations for either observation, vaginal brachytherapy or external pelvic beam radiotherapy.
Journal ArticleDOI
Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC).
TL;DR: The cetuximab group experienced significantly more toxicity--grade ≥3 oral mucositis, skin dermatitis, ≥10% weight loss, and enteral feeding requirement than a matched cisplatin group.
Journal ArticleDOI
Change in Patterns of Failure After Image-Guided Brachytherapy for Cervical Cancer: Analysis From the RetroEMBRACE Study.
Li Tee Tan,Richard Pötter,Alina Sturdza,Lars Fokdal,Christine Haie-Meder,Maximilian Schmid,Deborah Gregory,Primoz Petric,Ina M. Jürgenliemk-Schulz,C. Gillham,Eric Van Limbergen,Peter Hoskin,Ekkasit Tharavichitkul,E. Villafranca,Umesh Mahantshetty,Christian Kirisits,Jacob Christian Lindegaard,Kathrin Kirchheiner,Kari Tanderup +18 more
TL;DR: Effective treatments to eradicate micrometastases in PAN and distant organs are needed in addition to IGABT and chemoradiation therapy to maximize local, regional, PAN, and systemic control and improve survival.